Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 23, 2018 11:21 ET | Source: Theratechnologies

Theratechnologies annonce une entente avec le AIDS Drug Assistance Program (ADAP) visant Trogarzo(MC) et EGRIFTA(MD)

MONTRÉAL, 23 mai 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX:TH) est heureuse d’annoncer qu’elle a conclu une entente de prix avec le AIDS Drug Assistance Program Crisis Task Force aux...
May 23, 2018 11:21 ET | Source: Theratechnologies

Theratechnologies Announces Agreement With AIDS Drug Assistance Program (ADAP) for Trogarzo™ and EGRIFTA®

MONTREAL, May 23, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX:TH) is pleased to announce that it has reached a pricing agreement with the AIDS Drug Assistance Program Crisis Task Force. The...
May 16, 2018 11:30 ET | Source: Theratechnologies

Annonces en marge de l’assemblée annuelle de Theratechnologies

MONTRÉAL, 16 mai 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. (TSX:TH) a tenu aujourd’hui son assemblée annuelle des actionnaires. Au cours de l’assemblée, les actionnaires ont élu les...
May 16, 2018 11:30 ET | Source: Theratechnologies

Announcements In Conjunction With Theratechnologies Annual Meeting

MONTREAL, May 16, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX:TH) today held its annual meeting of shareholders. As part of the meeting, shareholders proceeded to elect the Company’s Board...
May 16, 2018 11:30 ET | Source: Theratechnologies

Theratechnologies fournit une mise à jour quant aux prescriptions et au remboursement de Trogarzo(MC) (ibalizumab-uiyk) injection

MONTRÉAL, 16 mai 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX:TH) a fait part aujourd’hui, lors de l’assemblée annuelle des actionnaires, d’informations relatives au nombre de...
May 16, 2018 11:30 ET | Source: Theratechnologies

Theratechnologies Provides Update on Trogarzo™ (Ibalizumab-Uiyk) Injection Prescriptions and Reimbursement Status

MONTREAL, May 16, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX:TH) today disclosed, during its annual meeting, information on the number of scripts and reimbursement coverage for Trogarzo™...
May 11, 2018 08:00 ET | Source: Theratechnologies

Theratechnologies annonce que les National Institutes of Health appuieront une étude avec EGRIFTA(MD) (tésamoréline pour injection) chez des patients séro-négatifs atteints de stéatose hépatique non alcoolique

MONTRÉAL, 11 mai 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX:TH) a annoncé aujourd’hui today que le National Institute of Diabetes and Digestive and Kidney Diseases des National...
May 11, 2018 08:00 ET | Source: Theratechnologies

Theratechnologies Announces That National Institutes of Health Will Support Study on EGRIFTA® (Tesamorelin for Injection) in Non-HIV Patients With Non-Alcoholic Fatty Liver Disease

MONTREAL, May 11, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX:TH) today announced that the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of...
May 01, 2018 07:30 ET | Source: Theratechnologies

La FDA dégage Theratechnologies de ses obligations post-approbation en lien avec EGRIFTA(MD) (tésamoréline pour injection)

MONTRÉAL, 01 mai 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) a annoncé aujourd’hui que la Food and Drug Administration (FDA) dégage Theratechnologies de ses...
May 01, 2018 07:30 ET | Source: Theratechnologies

FDA Releases Theratechnologies from Post-Approval Commitments Related to EGRIFTA® (Tesamorelin for Injection)

MONTREAL, May 01, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced that the Food and Drug Administration (FDA) has released Theratechnologies from...